The primary aim of this study is to assess the incremental benefit of adjuvant behavioral therapy with the transdermal nicotine patch (TNP) for smoking cessation in inner-city African Americans. This 4 year randomized intervention trial will be conducted at two community-based clinics. The primary outcome of the study is biochemically-verified continuous abstinence from cigarettes at 6 months from the end-of-treatment. Secondary outcomes include 1) continuous, 30-day, and 7-day abstinence at one year; 2) differences among, and within, the three groups in advancing along the stages of change continuum; and, 3) cost-effectiveness, as measured by cost-per-successful quitter. This two arm study has one comparison group (c) and one intervention group (Tx1). Group 1 (Comparison = C) will receive usual care, typical of a primary care setting, consisting of brief physician advice and a previously developed culturally-sensitive smoking cessation guide written at the sixth grade reading level (Pathways to Freedom). Group 2 (Boosted Self-Help = Tx1) will receive the same as C with the addition of a culturally-sensitive smoking cessation video (Kick-It!), a baseline individual counseling session, and four stage-based booster phone calls, the goals of which are, to encourage quitting, to increase use of the written and audiovisual materials, and to maintain compliance with TNP. There will be six data collection points: 1) at screening, in person; 2) at baseline, in person; 3) at 6 weeks, in person; 4) at 10 weeks (the end-of-treatment), by telephone; 5) at six months, in person; and, 6) at one year, by telephone. Recruitment and retention of subjects will be enhanced by phone and mailed reminders to pick up remaining TNP at six weeks and to return for the six month visit, by a monetary stipend for return at the sixth month visit, and by home visits at six months for no shows. The intervention groups have been designed so that efficacy, durability, and generalizabilty, can be accurately measured and assessed. This randomized controlled trial will use the patient as the unit of randomization and analysis. We project that 400 smokers for C, and 400 for Tx1, a total of 800 patients, will be required at baseline to detect proposed treatment effects for the primary outcome with a power of 80%. Ultimately, we envision that the interventions, if efficacious, could be used as a pre-packaged intervention and be distributed at settings such as churches and social service agencies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA077856-03
Application #
2896483
Study Section
Special Emphasis Panel (ZRG2-SSP (01))
Project Start
1997-09-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Kansas
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Thomas, Janet L; Guo, Hongfei; Lynam, Ian M et al. (2008) The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers. J Gen Intern Med 23:1361-6
Catley, Delwyn; Harris, Kari Jo; Okuyemi, Kolawole S et al. (2005) The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine Tob Res 7:859-70
Manning, Brian K; Catley, Delwyn; Harris, Kari Jo et al. (2005) Stress and quitting among african american smokers. J Behav Med 28:325-33
Boardman, Thuy; Catley, Delwyn; Mayo, Matthew S et al. (2005) Self-efficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med 12:266-72
Harris, Kari Jo; Okuyemi, Kolawole S; Catley, Delwyn et al. (2004) Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 38:498-502
Koontz, Jennifer Scott; Harris, Kari Jo; Okuyemi, Kolawole S et al. (2004) Healthcare providers' treatment of college smokers. J Am Coll Health 53:117-25
Okuyemi, Kolawole S; Ahluwalia, Jasjit S; Ebersole-Robinson, Maiko et al. (2003) Does menthol attenuate the effect of bupropion among African American smokers? Addiction 98:1387-93
Harris, Kari Jo; Ahluwalia, Jasjit S; Catley, Delwyn et al. (2003) Successful recruitment of minorities into clinical trials: The Kick It at Swope project. Nicotine Tob Res 5:575-84
Woods, Malaika N; Harris, Kari Jo; Mayo, Matthew S et al. (2002) Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. J Natl Med Assoc 94:609-18
Ahluwalia, Jasjit S; Richter, Kimber; Mayo, Matthew S et al. (2002) African American smokers interested and eligible for a smoking cessation clinical trial: predictors of not returning for randomization. Ann Epidemiol 12:206-12

Showing the most recent 10 out of 18 publications